Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quoin Pharmaceuticals

8.89
-0.1202-1.33%
Post-market: 8.890.00000.00%18:41 EDT
Volume:2.52K
Turnover:22.69K
Market Cap:5.23M
PE:-0.23
High:9.01
Open:9.01
Low:8.89
Close:9.01
Loading ...

Quoin Pharmaceuticals CFO Departure Announcement

TIPRANKS
·
09 Jul

Quoin Pharmaceuticals Announces Upcoming Departure of CFO Gordon Dunn

Reuters
·
09 Jul

Quoin Pharmaceuticals releases new ‘NETHERTON NOW’ video

TIPRANKS
·
26 Jun

Quoin Pharmaceuticals Receives FDA Rare Disease Designation

TIPRANKS
·
25 Jun

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome

Reuters
·
24 Jun

Quoin Pharmaceuticals Updates Shareholder Proposal Deadlines

TIPRANKS
·
21 Jun

Quoin Pharmaceuticals Ltd. Announces 2024 Annual Cash Bonuses for CEO and COO

Reuters
·
05 Jun

Quoin Pharmaceuticals Says US FDA Clears Second Netherton Syndrome Pivotal Study

MT Newswires Live
·
22 May

Quoin Pharmaceuticals’ QRX003 Gains Orphan Drug Status

TIPRANKS
·
21 May

Quoin Pharmaceuticals Announces EMA Orphan Drug Designation for QRX003, Advancing Late-Stage Trials for Netherton Syndrome Treatment

Reuters
·
21 May

Quoin Pharmaceuticals announces EMA grants ODD for QRX003

TIPRANKS
·
20 May

Quoin Pharmaceuticals Reports Q1 2025 Progress and Financials

TIPRANKS
·
16 May

Quoin Pharmaceuticals Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Quoin Pharmaceuticals Q1 EPS $(6.50) Misses $(6.07) Estimate

Benzinga
·
13 May

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

Dow Jones
·
13 May

Quoin Pharmaceuticals Ltd expected to post a loss of $6.07 a share - Earnings Preview

Reuters
·
09 May

Quoin Pharmaceuticals Ltd expected to post a loss of $6.07 a share - Earnings Preview

Reuters
·
05 May

Quoin Pharmaceuticals Regains Compliance With Nasdaq

Reuters
·
30 Apr

Quoin Pharmaceuticals regains compliance with Nasdaq minimum bid price rule

TIPRANKS
·
30 Apr

Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

GlobeNewswire
·
30 Apr